Login

Financial Snapshot

Revenue
TTM
$0.00
Gross Margin
Last 4 Quarters
N/A
Net Income
TTM
-$56.88M
Current Assets
2026 Q1
$81.35M
Current Liabilities
2026 Q1
$10.45M
Current Ratio
2026 Q1
778.6%
Total Assets
2026 Q1
$108.8M
Total Liabilities
2026 Q1
$39.42M
Book Value
2026 Q1
69.35M
Cash
2026 Q1
$4.636M
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$32.76M

Stock Price

Loading...
Market Cap: $785.93 Million

About Alpha Tau Medical Ltd

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The firm has one subsidiary Healthcare Capital Corp.

Industry: Surgical & Medical Instruments & Apparatus Peers: Inmode Ltd Nano-X Imaging Ltd

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support